Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2022; 12(5): 171-177


A reflection of the lower rate of infectivity among comorbid conditions in multidrug-resistant tuberculosis

Smitha Thungathurthi, Prabhakar Orsu.




Abstract
Cited by 0 Articles

Tuberculosis (TB) is one of the main causes for death among people worldwide. There has been an increase in the incidence of drug-resistant TB. The effect of TB on various diseases has an impact on hematological parameters and it is an emerging problem in India. The impact of the medical condition on diabetes, hypothyroid, and retroviral disease (RVD) in multidrug resistance TB is investigated. The study highlights changes in hematological parameters in both genders. The study enrolled (N = 271) patients with drug resistance attending the district government hospital. The study observed normocytic normochromic anemia (n = 244) in most patients. Anemia was prevalent in female (n = 68) patients. A statistical significance was observed in hemoglobin (p < 0.0001***), hematocrit (p < 0.0001***), red cell indices between male and female patients. The study reported the drug-resistant TB more in diabetes than in hypothyroid and RVD patients. The clinical conditions such as diabetes, hypothyroid, RVD in multidrug resistance TB established significant changes in cell counts of white cells (p = 0.03* ), monocytes (p < 0.0002***), and immature granulocytes (p < 0.009**). Monitoring anemia in TB is essential, and it is pertinent to monitor anemia in female patients as a prerequisite. The drug resistance TB worsened the hematological parameters compared to the comorbid conditions with drug resistance TB.

Key words: Drug resistant tuberculosis, hematological parameters, gender, medical conditions, differences.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.